Dialytic phosphate removal: A modifiable measure of dialysis efficacy in automated peritoneal dialysis

Peritoneal Dialysis International

Volumn 29, Issue 4, 2009, Pages 465-471

  Schmitt, Claus P ^a   Borzych, Dagmara ^a,b   Nau, Barbara ^a   Wühl, Elke ^a   Zurowska, Aleksandra ^b   Schaefer, Franz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adequacy; Children; Peritoneal transport; Phosphate clearance

Indexed keywords

CREATINE; PHOSPHATE; PHOSPHATE BINDING AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSATE; HUMAN; HYPERPHOSPHATEMIA; INFANT; KIDNEY FAILURE; MEMBRANE TRANSPORT; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 70349512221     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900414     Document Type: Article

References (30)

1. Churchill DN, Taylor DW, Keshaviah PK, Thorpe KE, Beecroft ML, Kailash KK, et al. Adequacy of dialysis and nutrition in continuous peritoneal dialysis; association with clinical outcome. CANUSA study. J Am Soc Nephrol 1996; 7:198-207.
2. NKF-K/DOQI. Clinical Practice Guidelines for Peritoneal Dialysis Adequacy, New York, National Kidney Foundation 2000. Am J Kidney Dis 2000; 6(Suppl 1):65-136.
3. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
4. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, et al. Effect of Kt/ V on survival and clinical outcome in CAPD patients in a prospective, randomized trial. Kidney Int 2003; 64:649-56.
5. Chertow GM. Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol 2003; 14(9 Suppl 4):S310-14.
6. Block GA, Hulbert-Shearon TE, Lewin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31:607-17.
7. Ganesh SK, Stack AG, Lewin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12:2131-8.
8. Stevens LA, Djurdiew O, Cardew S, Cameron EC, Levin A. Phosphate and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004; 15:770-9.
9. Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 2006; 21:2513-20.
10. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 2006; 70:351-7.
11. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106:100-5.
12. Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16:1494-500.
13. Fischbach M, Stefanidis CJ, Watson AR; European Pediatric Peritoneal Dialysis Working Group. Guidelines by an ad hoc European committee on adequacy of the pediatric peritoneal dialysis prescription. Nephrol Dial Transplant 2002; 17:380-5.
14. Fischbach M, Edefonti A, Schroeder C, Watson A; European Pediatric Dialysis Working Group. Hemodialysis in children: general practical guidelines. Pediatr Nephrol 2005; 20:1054-6.
15. Fischbach M, Lahlou A, Eyer D, Desprez P, Geisert J. Determination of individual ultrafiltration time (APEX) and purification phosphate time by peritoneal equilibration test: application to individual peritoneal dialysis modality prescription in children. Perit Dial Int 1996; 16(Suppl 1):S557-60.
16. Fischbach M, Desprez P, Terzic J, Lahlou A, Mengus L, Geisert J. Use of intraperitoneal pressure, ultrafiltration and purification dwell times for individual peritoneal dialysis prescription in children. Clin Nephrol 1996; 46: 14-16.
17. Schaefer F, Langenbeck D, Heckert HK, Scharer K, Mehls O. Evaluation of peritoneal solute transfer by peritoneal equilibration test in children. Adv Perit Dial 1992; 8:410-15.
18. NKF-K/DOQI. Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005; 46(Suppl 1):S1-122.
19. Graff J, Fugleberg S, Brahm J, Fogh-Andersen N. The transport of phosphate between the plasma and dialysate compartments in peritoneal dialysis is influenced by an electronic potential difference. Clin Physiol 1996; 16: 291-300.
20. Virkki LV, Biber J, Murer H, Forster IC. Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol 2007; 293:F643-F654.
21. Shoemaker DG, Bender CA, Gunn RB. Sodium-phosphate cotransport in human red blood cells. Kinetics and role in membrane metabolism. J Gen Physiol 1988; 92:449-74.
22. Warady BA, Jennings J. The short PET in pediatrics. Perit Dial Int 2007; 27:441-5.
23. Salusky IB. A new era in phosphate binder therapy: what are the options? Kidney Int Suppl 2006; 105:S10-15.
24. Mesa P, Gropuzzo M, Cleva M, Boscutti G, Mioni G, Cruciatti A, et al. Behaviour of phosphate removal with different dialysis schedules. Nephrol Dial Transplant 1998; 13(Suppl 6):43-8.
25. Winchester JF, Quijda VE, Rotellar C. Phosphate control in peritoneal dialysis patients. In: La Greca, eds. Peritoneal Dialysis. Milan: Wichtig; 1991: 327-31.
26. Mostellar ME, Tuttle EP Jr. Effects of alkalosis on plasma concentration and urinary excretion of inorganic phosphate. J Clin Invest 1964; 43:138-49.
27. Fischbach M, Hamel G, Simeoni U. Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate buffer dialysate). Nephron 1992; 62:155-60.
28. Schmitt CP, Harraldson B, Doetschmann R, Zimmering M, Greiner C, Boswald M, et al. Kidney Int 2002; 61:1527-36.
29. Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, et al. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol 2003; 14:2632-8.
30. Sedlacek M, Dimaano F, Uribarri J. Relationship between phosphorus and creatinine clearance in peritoneal dialysis: clinical implications. Am J Kidney Dis 2000; 36:1020-4.